Repare Therapeutics【RPTX】株式ニュース

名称	銘柄コード	市場	種別
Repare Therapeutics Inc	RPTX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.12	3.09%	4.00	08:50:00

始値	安値	高値	終値	前日終値
3.84	3.63	4.04	4.00	3.88

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/10	20:05	BW	Repare Therapeutics Doses First Patient in Camonsertib..
2024/6/05	05:05	BW	Repare Therapeutics Announces Fast Track Designation Granted..
2024/6/04	05:05	BW	Repare Therapeutics to Participate in the Goldman Sachs 45th..
2024/5/29	20:05	BW	Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data..
2024/5/25	05:06	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/5/08	23:10	APS	Small Cap Massively Bid Following Key Q1 Earnings Beat
2024/5/08	05:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/08	05:05	BW	Repare Therapeutics Provides Business and Clinical Update..
2024/4/30	20:05	BW	Debiopharm & Repare Therapeutics Announce First Patient..
2024/4/27	05:05	BW	Repare Therapeutics Appoints Steven H. Stein, M.D. to its..
2024/3/06	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	11:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	11:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/29	21:05	BW	Repare Therapeutics to Participate in Two Upcoming Investor..
2024/2/29	06:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/2/28	21:15	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/28	21:10	EDGAR2	Form 8-K - Current report
2024/2/28	21:05	BW	Repare Therapeutics Provides Business Update and Reports..
2024/2/15	21:05	BW	Repare Therapeutics Doses First Patient in Phase 1 Clinical..
2024/2/15	11:02	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/14	22:54	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/13	06:48	EDGAR2	Form 8-K - Current report
2024/2/13	06:05	BW	Repare Therapeutics to Regain Global Rights to Camonsertib
2024/1/26	04:29	EDGAR2	Form 8-K - Current report
2024/1/25	21:00	BW	Repare Therapeutics Announces Achievement of $40 Million..
2024/1/13	06:05	EDGAR2	Form 8-K - Current report
2024/1/08	21:00	BW	Repare Therapeutics Provides Corporate Update and Highlights..
2024/1/05	06:05	BW	Repare Therapeutics and Debiopharm Partner to Explore the..
2023/12/30	06:05	BW	Repare Therapeutics Insiders Establish Automatic Securities..
2023/12/13	06:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/15	21:20	EDGAR2	Form 8-K - Current report
2023/11/15	21:00	BW	Repare Therapeutics Unveils Two Programs Expected to Enter..
2023/11/09	21:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09	21:05	EDGAR2	Form 8-K - Current report
2023/11/09	21:00	BW	Repare Therapeutics Provides Business Update and Reports..
2023/11/07	21:00	BW	Repare Therapeutics to Host Investor and Analyst Conference..
2023/11/06	21:00	BW	Repare Therapeutics to Participate in Two Upcoming Investor..
2023/10/14	06:15	EDGAR2	Form 8-K - Current report
2023/10/13	22:47	EDGAR2	Form 8-K - Current report
2023/10/13	22:40	BW	Repare Therapeutics Announces Positive Initial Data from..
2023/10/06	20:56	EDGAR2	Form 8-K - Current report
2023/10/03	20:00	BW	Repare Therapeutics to Host Conference Call and Webcast to..
2023/9/19	20:00	BW	Repare Therapeutics to Present Preliminary Phase 1 MYTHIC..
2023/9/06	20:00	BW	Repare Therapeutics to Participate at the Morgan Stanley..
2023/8/10	05:12	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/10	05:09	EDGAR2	Form 8-K - Current report
2023/8/10	05:05	BW	Repare Therapeutics Provides Business Update and Reports..